Next-generation berberine formulation developed with BioSOLVE Technology targets metabolic health, blood sugar balance, and weight management
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
Nearly one in five women worldwide are now living with obesity
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
